All Medical Microbiology articles
-
NewsResearchers find increased bacteria infection in patients with chronic lung disease
A new study has found that people with bronchiectasis and chronic sinus disease were more likely to have mucus samples that tested positive for Pseudomonas aeruginosa. It suggests that doctors caring for patients with bronchiectasis may need to pay closer attention to sinus disease and bacterial testing.
-
NewsEurope advances genomic surveillance of CCRE with landmark multi-country study
New survey results provide the most comprehensive genomic picture to date of carbapenem- and/or colistin-resistant Enterobacterales (CCRE) across hospitals in Europe.
-
NewsBronchiectasis and NTM Care Center Network expands to 62 centers
The Bronchiectasis and NTM Association has accepted one new Care Center and three new Clinical Associate Center sites into the Bronchiectasis and NTM Care Center Network (CCN). The CCN includes 62 centers across the United States.
-
NewsLAMECS 2026 set to bring the next generation of microbiologists to Manchester
The future of applied microbiology takes centre stage in Manchester next month as the Letters in Applied Microbiology Early Career Scientist Research Symposium (LAMECS) returns for its fifteenth year.
-
NewsFDA approves early warning system for sepsis
An early warning system for sepsis, one of the deadliest infections for hospital patients, has been approved for use by the FDA, one of the first AI-based medical tools to get clearance. The tool detects sepsis hours faster than doctors and has reduced deaths by nearly 20%.
-
NewsResearchers develop next-generation CRISPR biocontainment technology for controlling microbial survival without DNA cleavage
Researchers have employed a CRISPR-dCas9-based base editing system capable of introducing precise nucleotide changes without inducing DNA double-strand breaks. The researchers targeted the start codons of essential genes and irreversibly disrupted their function, permanently blocking cell survival.
-
NewsExpanded tuberculosis screening does not speed up treatment initiation or improve survival in hospitalized patients with HIV
According to the EXULTANT trial, adding molecular tests on sputum, urine and stool samples does not appear to outperform the standard WHO-recommended diagnostic approach.
-
NewsNeedle-free flu vaccine aims to boost children’s immunity
A new study will explore the effects of a nasal spray flu vaccine on children’s immune systems, aiming to boost future protection and lower vaccine hesitancy rates.
-
NewsLong-term dynamic virological response patterns and clinical outcomes in hepatitis B virus-related cirrhosis
The long-term clinical outcomes of patients with hepatitis B virus (HBV)-related cirrhosis receiving nucleos(t)ide analog (NA) therapy according to virological response patterns remain inadequately defined. A new study aimed to investigate the association between virological response patterns and clinical outcomes.
-
NewsResearchers find diagnostic delays are common for US pediatric patients with malaria
Researchers found that more than one in four pediatric patients treated for malaria in the United States had a delay in their initial diagnosis, increasing the risk of more severe infection.
-
NewsPolymer ‘bristles’ could help repel proteins — and germs — from surfaces in medical settings
A non-toxic coating made of polydimethylsiloxane prevents proteins from sticking to surfaces — potentially offering a new tool in the fight against hospital-acquired infections.
-
NewsPhage therapy at a turning point: Valencia 2026 to define the next era of antibacterial medicine
The Targeting Phage Therapy 2026 Congress will bring together leading scientists, clinicians, microbiologists, engineers, biotech leaders, regulators, hospital teams, start-ups, and innovators to ask: How can phage therapy move from promising science to accessible, validated, and deployable medicine?
-
NewsEight-year results from two randomized phase 3 trials of tenofovir alafenamide for chronic hepatitis B virus infection in China
Tenofovir alafenamide (TAF) has demonstrated comparable efficacy to tenofovir disoproxil fumarate (TDF), with improved renal and bone safety, in Chinese participants with chronic hepatitis B enrolled in two Phase 3 trials.
-
NewsCOVID antiviral speeds recovery but doesn’t reduce hospitalization in vaccinated patients, trials find
Paxlovid (nirmatrelvir-ritonavir) does not reduce hospital admissions or deaths in vaccinated adults at higher risk of severe COVID-19, despite helping them recover faster, according to results from two national trials.
-
NewsThe cold virus ‘hides’ and multiplies in the tonsils and adenoids, even in people without symptoms
A study reveals that tissues such as the tonsils and adenoids can serve as hiding places for the rhinovirus, which causes the common cold. The pathogen can persist in these tissues for long periods, be transmitted unexpectedly, and trigger new outbreaks of the disease.
-
NewsMeasles vaccine gaps persist among ER patients
A study has found critical gaps in knowledge, vaccination status, and acceptance of the measles, mumps, and rubella (MMR) vaccine among patients visiting emergency departments across the United States. It examines how misinformation and access barriers may contribute to declining vaccination rates.
-
NewsStudy finds blood pressure drug effective for treating antibiotic-resistant bacteria
A new study reports that a drug used to lower blood pressure could also be the basis of a promising new treatment for methicillin-resistant Staphylococcus aureus (MRSA). Candesartan cilexetil not only killed MRSA bacteria at different growth stages, but also reduced the formation of biofilms.
-
NewsModeling premature aging in yeast reveals key effects of progerin on cellular lifespan
Researchers developed a yeast-based model to study premature aging by expressing Progerin, the toxic protein responsible for Hutchinson–Gilford Progeria Syndrome. Using genetically engineered yeast cells, they compared the effects of Progerin with its normal counterpart, Lamin A.
-
NewsLong-term cure rates for multidrug-resistant tuberculosis much better than expected
A new national cohort study from Latvia provides important insights into the treatment of multidrug-resistant tuberculosis (MDR-TB). The study shows that long-term disease-free survival rates are significantly higher than previous standard indicators suggest.
-
NewsGlobal strategy to combat drug‑resistant fungi is about to change
An increasing number of fungi are becoming resistant to medication, posing serious risks for patients with weakened immune systems. That is why fifty researchers from around the world are calling for action against drug‑resistant fungi.